Long-term ketamine infusion-induced cholestatic liver injury in COVID-19-associated acute respiratory distress syndrome

Long-term ketamine infusion-induced cholestatic liver injury in COVID-19-associated acute respiratory distress syndrome

Abstract Background A higher-than-usual resistance to standard sedation regimens in COVID-19 patients suffering from acute respiratory distress syndrome (ARDS) has led to the frequent use of the second-line anaesthetic agent ketamine. Simultaneously, an increased incidence of cholangiopathies in mec...

Full description

Bibliographic Details
Main Authors: Pedro David Wendel-Garcia, Rolf Erlebach, Daniel Andrea Hofmaenner, Giovanni Camen, Reto Andreas Schuepbach, Christoph Jüngst, Beat Müllhaupt, Jan Bartussek, Philipp Karl Buehler, Rea Andermatt, Sascha David
Format: Article
Language:English
Published: BMC 2022-05-01
Series:Critical Care
Subjects:
Hypnotics and sedatives
Chemical and drug-induced liver injury
Cholestasis
Cholangitis
Cholangiopathy
Online Access:https://doi.org/10.1186/s13054-022-04019-8

Internet

https://doi.org/10.1186/s13054-022-04019-8

Similar Items